Albany Molecular Research Inc.

Article

Join AMRIat Chemspec Europe this year in the SOCMA Pavilion (Booth #G01H), from June 24-25, 2015, in Cologne, Germany, to learn more about our API Manufacturing solutions.

 

 

Join Albany Molecular Research Inc. (AMRI) at Chemspec Europe this year in the SOCMA Pavilion (Booth #G01H), from June 24-25, 2015, in Cologne, Germany. Chemspec is the perfect opportunity to learn more about how we can provide you with the essential expertise to support the development and the cGMP manufacture of your custom and complex Active Pharmaceutical Ingredients (API).

To help you progress your complex compounds, our API Manufacturing business is at the ready to support the production of your complex, formulated drug product, from grams to hundreds of kilograms. Our global manufacturing footprint, which also includes manufacturing in India, provides you with access to global markets and low-cost manufacturing of APIs and intermediates.

 

Core Competencies Include:

 

  • Niche APIs

  • Potent Compounds

  • Process Chemistry

  • Chromatographic Separations

  • Clinical Drug Substance

  • Conjugation Chemistry

  • Controlled Substances

  • Commercial-Phase Validations

  • Steroids, Prostaglandins & Vitamin D Analogs

 

High Potency & Pilot Plant Production

We provide full-service GMP-warehousing with ambient, USP, refrigerated and freezer storage conditions, and approach quality on a GMP continuum, ensuring the correct quality measures are in place for each stage of a drug development project. Our capabilities include hydrogenations, esterifications, Friedel-Crafts acylations, low-temperature Grignards, chlorination, bromination, Palladium-catalyzed couplings, chiral resolutions, peptide couplings and others.

 

Contact Details:
Albany Molecular Research Inc.
Email: Lisa.Peterson@amriglobal.comWeb Address: Click here to schedule a meeting with us at Chemspec Europe in Cologne, Germany

 

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Drug Digest: Focusing on Solid Dosage Trends and Demand
Behind the Headlines, episode 7
Related Content